Clinical Trial Update: Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This update covers a Phase 2 neoadjuvant trial using FDR GX in locally advanced pancreatic cancer, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FDR GX

Snippet

Sponsor: Asan Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED